- Home
- ONFO vs ALBT Comparison
ONFO vs ALBT Comparison
Compare ONFO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONFO
- ALBT
- Stock Information
- Founded
- ONFO 2018
- ALBT 2014
- Country
- ONFO United States
- ALBT United States
- Employees
- ONFO N/A
- ALBT N/A
- Industry
- ONFO Computer Software: Programming Data Processing
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONFO Technology
- ALBT Health Care
- Exchange
- ONFO Nasdaq
- ALBT Nasdaq
- Market Cap
- ONFO 5.4M
- ALBT 5.7M
- IPO Year
- ONFO 2022
- ALBT N/A
- Fundamental
- Price
- ONFO $1.31
- ALBT $2.27
- Analyst Decision
- ONFO
- ALBT
- Analyst Count
- ONFO 0
- ALBT 0
- Target Price
- ONFO N/A
- ALBT N/A
- AVG Volume (30 Days)
- ONFO 83.7K
- ALBT 662.4K
- Earning Date
- ONFO 08-13-2025
- ALBT 08-18-2025
- Dividend Yield
- ONFO N/A
- ALBT N/A
- EPS Growth
- ONFO N/A
- ALBT N/A
- EPS
- ONFO N/A
- ALBT N/A
- Revenue
- ONFO $9,087,118.00
- ALBT $807,235.00
- Revenue This Year
- ONFO N/A
- ALBT N/A
- Revenue Next Year
- ONFO N/A
- ALBT N/A
- P/E Ratio
- ONFO N/A
- ALBT N/A
- Revenue Growth
- ONFO 65.97
- ALBT N/A
- 52 Week Low
- ONFO $0.61
- ALBT $2.11
- 52 Week High
- ONFO $1.88
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- ONFO 61.62
- ALBT 37.00
- Support Level
- ONFO $1.25
- ALBT $2.15
- Resistance Level
- ONFO $1.42
- ALBT $2.52
- Average True Range (ATR)
- ONFO 0.14
- ALBT 0.22
- MACD
- ONFO 0.02
- ALBT 0.00
- Stochastic Oscillator
- ONFO 64.81
- ALBT 12.00
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.